Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 10Carcinoma, Non-Small-Cell Lung 9Fallopian Tube Neoplasms 7Ovarian Neoplasms 6Colorectal Neoplasms 5Urinary Bladder Neoplasms 4Pancreatic Neoplasms 4Melanoma 4Carcinoma, Hepatocellular 4Glioblastoma 3Colonic Neoplasms 3Carcinoma, Renal Cell 3Brain Neoplasms 3Urethral Neoplasms 2Ureteral Neoplasms 2Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Prostatic Neoplasms 2Neoplasm Metastasis 2Nasopharyngeal Carcinoma 2Multiple Myeloma 2Lymphoma, Large B-Cell, Diffuse 2Lymphoid Interstitial Pneumonia 2Liposarcoma 2Carcinoma, Neuroendocrine 2Carcinoma 2Brenner Tumor 2Breast Neoplasms 2Adenocarcinoma, Mucinous 2

Interventions

Carboplatin 3Taxes 2Radiotherapy 2Radiosurgery 2Radiation 2Paclitaxel 2Nivolumab 2veliparib 1tislelizumab 1spartalizumab 1sotorasib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1enzalutamide 1apatinib 1Radiotherapy, Image-Guided 1Radiotherapy, Conformal 1Platinum 1Pemetrexed 1Morphine 1Midazolam 1Letrozole 1Ipilimumab 1Immunoglobulin G 1Granulocyte Colony-Stimulating Factor 1Geriatric Assessment 1Fulvestrant 1Filgrastim 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Adenocarcinoma of Lung × Immunoglobulin G × Clear all
NCT00334815 2026-05-26

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Active not recruiting
29 enrolled 10 charts
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar

Data powered by HemOnc (CC BY 4.0) Colophon âš¡